{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:28:21Z","timestamp":1793600901045,"version":"4.5.0"},"reference-count":234,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neuroscience.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:12:09Z","timestamp":1776294729000},"page":"118-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Schizophrenia and frontotemporal dementia: distinct diseases with converging circuit dysfunctions"],"prefix":"10.1016","volume":"605","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7015-449X","authenticated-orcid":false,"given":"Antonino","family":"Casile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Sapienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-1940","authenticated-orcid":false,"given":"Valeria","family":"Vasciaveo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9046-6424","authenticated-orcid":false,"given":"Benedetta","family":"Barzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Nasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Guarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Ave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8726-8023","authenticated-orcid":false,"given":"Francesca","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5686-7194","authenticated-orcid":false,"given":"Stefano","family":"Comai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.04.003_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10060947","article-title":"Brain NMDA receptors in schizophrenia and depression","volume":"10","author":"Adell","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1037\/neu0000664","article-title":"Communicative-pragmatic abilities mediate the relationship between cognition and daily functioning in schizophrenia","volume":"35","author":"Agostoni","year":"2021","journal-title":"Neuropsychology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-021-00149-0","article-title":"Cognitive impairment in schizophrenia: relationships with cortical thickness in fronto-temporal regions, and dissociability from symptom severity","volume":"7","author":"Alkan","year":"2021","journal-title":"NPJ Schizophr."},{"issue":"362","key":"10.1016\/j.neuroscience.2026.04.003_b0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.aat0473","article-title":"Glia as architects of central nervous system formation and function","volume":"1979","author":"Allen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0025","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-220295","article-title":"The tryptophan catabolite or kynurenine pathway in Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"88","author":"Almulla","year":"2022","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0030","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.0511065103","article-title":"NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation","volume":"103","author":"Amadoro","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0035","first-page":"25","article-title":"Revisiting glutamate excitotoxicity in amyotrophic lateral sclerosis and age-related neurodegeneration","author":"Arnold","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbi.2006.02.005","article-title":"Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid","volume":"21","author":"Atlas","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000515066","article-title":"Galantamine-memantine combination and kynurenine pathway enzyme inhibitors in the treatment of neuropsychiatric disorders","volume":"7","author":"Bai","year":"2021","journal-title":"Complex Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.comppsych.2016.08.012","article-title":"The communicative impairment as a core feature of schizophrenia: frequency of pragmatic deficit, cognitive substrates, and relation with quality of life","volume":"71","author":"Bambini","year":"2016","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0055","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","article-title":"Frontotemporal dementia","volume":"386","author":"Bang","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s007020050149","article-title":"Kynurenine metabolism in Alzheimer\u2019s disease","volume":"106","author":"Baran","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.117725","article-title":"Neurophysiological and neuropharmacological effects of melatonin MT2 receptors activation in MK-801-induced schizophrenia-like dysfunctions","author":"Barzon","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2008.06.012","article-title":"Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia","volume":"104","author":"Bauer","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fnins.2019.00304","article-title":"Toward a glutamate hypothesis of frontotemporal dementia","volume":"13","author":"Benussi","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/acn3.683","article-title":"In vivo evidence for pre\u2010symptomatic neuroinflammation in a MAPT mutation carrier","volume":"6","author":"Bevan-Jones","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0085","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/wps.20577","article-title":"Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis","volume":"17","author":"Bighelli","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0090","first-page":"52","article-title":"The role of cytokines in schizophrenia","volume":"62","author":"Bini\u0107","year":"2023","journal-title":"Acta Med. Med."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ynstr.2018.05.003","article-title":"Chronic stress as a risk factor for Alzheimer\u2019s disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress","volume":"9","author":"Bisht","year":"2018","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1113\/jphysiol.1973.sp010273","article-title":"Long\u2010lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path","volume":"232","author":"Bliss","year":"1973","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000512082","article-title":"Cognition in schizophrenia: modeling the interplay between interleukin-1\u03b2 C-511T polymorphism, metabolic syndrome, and sex","volume":"80","author":"Bosia","year":"2021","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0110","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41380-018-0133-2","article-title":"Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness","volume":"24","author":"Bradshaw","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/1673-5374.198971","article-title":"Kynurenine pathway metabolism and neuroinflammatory disease","volume":"12","author":"Braidy","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120496","article-title":"Cognitive reserve profiles are associated with outcome in schizophrenia","volume":"443","author":"Buonocore","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0125","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40263-021-00836-7","article-title":"Relevance of 5-HT2A receptor modulation of pyramidal cell excitability for dementia-related psychosis: implications for pharmacotherapy","volume":"35","author":"Burstein","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0130","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3233\/JAD-161304","article-title":"Alterations in the peripheral immune system in dementia","volume":"58","author":"Busse","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0135","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00213-016-4218-9","article-title":"Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness","volume":"233","author":"Calcia","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0140","doi-asserted-by":"crossref","first-page":"246","DOI":"10.15698\/cst2018.10.157","article-title":"Astrocytes, emerging stars of energy homeostasis","volume":"2","author":"Camandola","year":"2018","journal-title":"Cell Stress"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0145","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/mp.2011.31","article-title":"A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior","volume":"17","author":"Carl\u00e9n","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-89335-9","article-title":"Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder","volume":"11","author":"Cathomas","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105783","article-title":"Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-\u03b2","volume":"171","author":"Cespedes","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0160","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.stemcr.2021.09.013","article-title":"Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3","volume":"16","author":"Chandrasekaran","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0165","doi-asserted-by":"crossref","unstructured":"Choe K, Bakker L, van den Hove DLA, Eussen SJPM, Kenis G, Ramakers IHGB, et al. 2025. Kynurenine pathway dysregulation in cognitive impairment and dementia: a systematic review and meta-analysis. Geroscience.","DOI":"10.1007\/s11357-025-01636-3"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0170","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/cercor\/bhx123","article-title":"A schizophrenia-related deletion leads to KCNQ2-dependent abnormal dopaminergic modulation of prefrontal cortical interneuron activity","volume":"28","author":"Choi","year":"2018","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-023-02746-5","article-title":"Peripheral inflammation in behavioural variant frontotemporal dementia: associations with central degeneration and clinical measures","volume":"20","author":"Chu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0180","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jagp.2016.03.013","article-title":"\u0392-amyloid burden is not associated with cognitive impairment in schizophrenia: a systematic review","volume":"24","author":"Chung","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0185","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s13760-020-01352-z","article-title":"Is that schizophrenia or frontotemporal dementia? Supporting clinicians in making the right diagnosis","volume":"120","author":"Cipriani","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0190","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1523\/JNEUROSCI.3712-12.2013","article-title":"Mechanistic and structural determinants of NMDA receptor voltage-dependent gating and slow Mg2+ unblock","volume":"33","author":"Clarke","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1113\/jphysiol.1983.sp014478","article-title":"Excitatory amino acids in synaptic transmission in the Schaffer collateral\u2010commissural pathway of the rat hippocampus","volume":"334","author":"Collingridge","year":"1983","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.acc.2019.08.005","article-title":"Tryptophan in health and disease","volume":"95","author":"Comai","year":"2020","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121618","article-title":"N-methyl-D-aspartate receptors and depression: linking psychopharmacology, pathology and physiology in a unifying hypothesis for the epigenetic code of neural plasticity","volume":"17","author":"Comai","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0210","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/NDT.S225643","article-title":"Negative symptoms in schizophrenia: a review and clinical guide for recognition, assessment, and treatment","volume":"16","author":"Correll","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0215","doi-asserted-by":"crossref","unstructured":"Craddock RM, Lockstone HE, Rider DA, Wayland MT, Harris LJW, McKenna PJ, et al. 2007. Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms. PLoS One 2.","DOI":"10.1371\/journal.pone.0000692"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1092852920001765","article-title":"Dementia-related psychosis and the potential role for pimavanserin","volume":"27","author":"Cummings","year":"2022","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0225","doi-asserted-by":"crossref","unstructured":"Cuoco F, Agostoni G, Lesmo S, Sapienza J, Buonocore M, Bechi M, et al. 2022. Get up! Functional mobility and metabolic syndrome in chronic schizophrenia: effects on cognition and quality of life. Schizophr. Res. Cogn. 28.","DOI":"10.1016\/j.scog.2022.100245"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0230","unstructured":"Cutting John, Shepherd Michael. 1987. The Clinical roots of the schizophrenia concept: translations of seminal European contributions on schizophrenia:238."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173849","article-title":"The role of cytokines in the pathogenesis of schizophrenia","volume":"10","author":"Dawidowski","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0240","doi-asserted-by":"crossref","first-page":"552","DOI":"10.15252\/embr.201541439","article-title":"The Tau\/A152T mutation, a risk factor for frontotemporal\u2010spectrum disorders, leads to NR 2B receptor\u2010mediated excitotoxicity","volume":"17","author":"Decker","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0245","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11126-017-9507-x","article-title":"Total Tau and phosphorylated Tau protein serum levels in patients with schizophrenia compared with controls","volume":"88","author":"Demirel","year":"2017","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0250","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-981-97-0048-6_11","article-title":"Animal Model for Alzheimer\u2019s Disease, Parkinson\u2019s disease, and schizophrenia","author":"Dhanasekaran","year":"2024","journal-title":"Anim. Models Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0255","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/brain\/awaa018","article-title":"Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders","volume":"143","author":"Ducharme","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.31887\/DCNS.2009.11.3\/rsduman","article-title":"Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression","volume":"11","author":"Duman","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0265","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biopsych.2010.09.038","article-title":"Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia","volume":"69","author":"Enomoto","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0270","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.biopsych.2016.12.011","article-title":"Adaptive and behavioral changes in kynurenine 3-monooxygenase knockout mice: relevance to psychotic disorders","volume":"82","author":"Erhardt","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0275","article-title":"Immune system abnormalities in schizophrenia: an integrative view and translational perspectives","volume":"13","author":"Ermakov","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0280","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1176\/appi.ajp.162.10.1824","article-title":"Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia","volume":"162","author":"Fanous","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0285","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbi.2024.08.030","article-title":"Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia \u2212 a GENFI study","volume":"122","author":"Fenoglio","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0290","first-page":"286","article-title":"The kynurenine pathway in Alzheimer\u2019s disease: a meta-analysis of central and peripheral levels","volume":"45","author":"Fernandes","year":"2023","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2014.00362","article-title":"The impact of microglial activation on blood-brain barrier in brain diseases","volume":"8","author":"da Fonseca","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0300","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1093\/brain\/awu172","article-title":"Pyramidal neurons of the prefrontal cortex in post-stroke, vascular and other ageing-related dementias","volume":"137","author":"Foster","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2019.02.001","article-title":"Linking phencyclidine intoxication to the tryptophan-kynurenine pathway: therapeutic implications for schizophrenia","volume":"125","author":"Fujigaki","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0310","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbi.2015.05.006","article-title":"Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers","volume":"49","author":"Galimberti","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0320","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1590\/0004-282x20190107","article-title":"Behavioral variant frontotemporal dementia in patients with previous severe mental illness: a systematic and critical review","volume":"77","author":"Gambogi","year":"2019","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0325","doi-asserted-by":"crossref","unstructured":"Gandal MJ, Sisti J, Klook K, Ortinski PI, Leitman V, Liang Y, et al. 2012. GABAB-mediated rescue of altered excitatory\u2013inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Transl. Psychiatry 2012 2:7 2:e142\u2013e142.","DOI":"10.1038\/tp.2012.69"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0330","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41380-021-01196-w","article-title":"Aberrant maturation and connectivity of prefrontal cortex in schizophrenia\u2014contribution of NMDA receptor development and hypofunction","volume":"27","author":"Gao","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0335","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1523\/JNEUROSCI.5835-11.2012","article-title":"Synaptic activity unmasks dopamine D2 receptor modulation of a specific class of layer V pyramidal neurons in prefrontal cortex","volume":"32","author":"Gee","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0340","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2010.254","article-title":"Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness","volume":"67","author":"Geser","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0345","doi-asserted-by":"crossref","DOI":"10.1042\/AN20110010","article-title":"Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade","volume":"3","author":"Ghiani","year":"2011","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0350","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/schbul\/sbn070","article-title":"GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia","volume":"34","author":"Gonzalez-Burgos","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0355","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1016\/j.febslet.2011.08.033","article-title":"Role of microglia in CNS inflammation","volume":"585","author":"Graeber","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.962957","article-title":"The role of gamma oscillations in central nervous system diseases: mechanism and treatment","volume":"16","author":"Guan","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(06)78001-1","article-title":"Neurobiology of dopamine in schizophrenia","volume":"78","author":"Guillin","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0370","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/09540261.2013.765389","article-title":"Schizophrenia and frontotemporal dementia: shared causation?","volume":"25","author":"Harciarek","year":"2013","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0375","doi-asserted-by":"crossref","unstructured":"Harvey PD, Bosia M, Cavallaro R, Howes OD, Kahn RS, Leucht S, et al. 2022. Cognitive dysfunction in schizophrenia: an expert group paper on the current state of the art. Schizophr Res. Cogn. 29.","DOI":"10.1016\/j.scog.2022.100249"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0380","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1503\/jpn.130277","article-title":"Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder","volume":"39","author":"Hercher","year":"2014","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0385","doi-asserted-by":"crossref","DOI":"10.3390\/ph16040615","article-title":"Brain kynurenine pathway metabolite levels may reflect extent of neuroinflammation in ALS, FTD and early onset AD","volume":"16","author":"Heylen","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0390","article-title":"Immunohistochemical and electrophysiological investigation of E\/I balance alterations in animal models of frontotemporal dementia","volume":"5","author":"Hill","year":"2021","journal-title":"Brain Neurosci. Adv."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0395","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1192\/bjp.142.6.547","article-title":"The concept of schizophrenia Kraepelin\u2013Bleuler\u2013Schneider","volume":"142","author":"Hoenig","year":"1983","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0400","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III \u2013 the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0405","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuroscience.2020.10.020","article-title":"Loss of dysbindin implicates synaptic vesicle replenishment dysregulation as a potential pathogenic mechanism in schizophrenia","volume":"452","author":"Hu","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0410","article-title":"Astrocytic RAR\u03b3 mediates hippocampal astrocytosis and neurogenesis deficits in chronic retinoic acid-induced depression","volume":"50","author":"Huang","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0415","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/NDT.S239763","article-title":"Increased plasma kynurenic acid levels are associated with impaired attention\/vigilance and social cognition in patients with schizophrenia","volume":"16","author":"Huang","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0420","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41380-021-01384-8","article-title":"Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration\u2014Insights into disease mechanisms and current therapeutic approaches","volume":"27","author":"Huber","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0425","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.wnl.0000191304.55196.4d","article-title":"A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia","volume":"66","author":"Huey","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0430","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.5213\/inj.1836214.107","article-title":"New roles for old glue: astrocyte function in synaptic plasticity and neurological disorders","volume":"22","author":"Hussaini","year":"2018","journal-title":"Int. Neurourol. J."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0435","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/biomedicines10071550","article-title":"NMDA and AMPA receptors at synapses: novel targets for tau and \u03b1-synuclein proteinopathies","volume":"10","author":"Italia","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0440","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1073\/pnas.0308455101","article-title":"NMDA receptor hypofunction produces concomitant firing rate potentiation burst activity reduction in the prefrontal cortex","volume":"101","author":"Jackson","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0445","doi-asserted-by":"crossref","unstructured":"Janssens J, Vermeiren Y, van Faassen M, van der Ley C, Kema IP, De Deyn PP. 2020. Monoaminergic and kynurenergic characterization of frontotemporal dementia and amyotrophic lateral sclerosis in cerebrospinal fluid and serum. Neurochem. Res. 45:1191.","DOI":"10.1007\/s11064-020-03002-5"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0450","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.pnpbp.2005.03.010","article-title":"Apoptotic mechanisms in the pathophysiology of schizophrenia","volume":"29","author":"Jarskog","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0455","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0165-5728(98)00226-4","article-title":"A central role for astrocytes in the inflammatory response to \u03b2- amyloid; chemokines, cytokines and reactive oxygen species are produced","volume":"93","author":"Johnstone","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0460","article-title":"Dysbindin-1, BDNF, and GABAergic transmission in schizophrenia","volume":"13","author":"Jun","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0465","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1523\/JNEUROSCI.0839-04.2004","article-title":"Identification of motifs involved in endoplasmic reticulum retention - Forward trafficking of the GLT-1 subtype of glutamate transporter","volume":"24","author":"Kalandadze","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0470","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2011.02.002","article-title":"Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice","volume":"42","author":"Kambe","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0475","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2018.12.017","article-title":"Neutrophil-to-lymphocyte ratio in schizophrenia: a systematic review and meta-analysis","volume":"206","author":"Karageorgiou","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0480","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2016.02.005","article-title":"Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder","volume":"54","author":"Karpi\u0144ski","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2018.06.033","article-title":"Blood-brain barrier regulation in psychiatric disorders","volume":"726","author":"Kealy","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0490","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psychres.2016.11.017","article-title":"Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity","volume":"247","author":"Kegel","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0495","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/neuro.02.006.2008","article-title":"Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia","volume":"1","author":"Kehrer","year":"2008","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0500","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.schres.2021.11.033","article-title":"The schizophrenia concept","volume":"242","author":"Kendler","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0505","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002030-199804000-00003","article-title":"Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex","volume":"12","author":"Kerr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0510","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-017-0071-9","article-title":"Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience","volume":"8","author":"Kesby","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.04.003_b0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-01888-7","article-title":"A high-resolution real-time quantification of astrocyte cytokine secretion under shear stress for investigating hydrocephalus shunt failure","volume":"4","author":"Khodadadei","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0520","first-page":"1","article-title":"Drosophila glia: models for human neurodevelopmental and neurodegenerative disorders","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0525","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41380-019-0401-9","article-title":"Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia","volume":"25","author":"Kindler","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0530","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1002\/alz.13162","article-title":"Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer\u2019s disease","volume":"19","author":"Knapskog","year":"2023","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0535","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.scog.2017.11.001","article-title":"Galantamine-memantine combination effective in dementia: translate to dementia praecox?","volume":"12","author":"Koola","year":"2018","journal-title":"Schizophr. Res. Cogn"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0540","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jamapsychiatry.2022.2075","article-title":"Exploring links between psychosis and frontotemporal dementia using multimodal machine learning: dementia praecox revisited","volume":"79","author":"Koutsouleris","year":"2022","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0545","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jamapsychiatry.2022.2075","article-title":"Exploring links between psychosis and frontotemporal dementia using multimodal machine learning","volume":"79","author":"Koutsouleris","year":"2022","journal-title":"JAMA Psychiat."},{"issue":"Suppl 6","key":"10.1016\/j.neuroscience.2026.04.003_b0550","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1528-1167.2012.03703.x","article-title":"Mechanisms underlying blood-brain barrier dysfunction in brain pathology and epileptogenesis: role of astroglia","volume":"53","author":"Kov\u00e1cs","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0555","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3233\/JAD-170608","article-title":"The pitfall of behavioral variant frontotemporal dementia mimics despitemultidisciplinary application oftheFTDC Criteria","volume":"60","author":"Krudop","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0560","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-003-1582-z","article-title":"NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development","volume":"169","author":"Krystal","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0565","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0570","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/AN20130017","article-title":"Astrocytes and glutamate homoeostasis in Alzheimer\u2019s disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex","volume":"5","author":"Kulijewicz-Nawrot","year":"2013","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0575","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0580","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1300.063","article-title":"Glutamate, dopamine, and schizophrenia from pathophysiology to treatment","volume":"1003","author":"Laruelle","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0585","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/bph.13364","article-title":"Microglial activation and progressive brain changes in schizophrenia","volume":"173","author":"Laskaris","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0590","first-page":"11","article-title":"Plasma levels of neuron- and astrocyte-derived exosomal amyloid Beta1-42, amyloid Beta1-40, and phosphorylated tau levels in schizophrenia patients and non-psychiatric comparison subjects: relationships with cognitive functioning and psychopathology","author":"Lee","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_bib1170","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.797072","article-title":"Overlapping genetic architecture between schizophrenia and neurodegenerative disorders","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0595","doi-asserted-by":"crossref","unstructured":"Li C, Pang D, Lin J, Yang T, Shang H. 2022a. Shared genetic links between frontotemporal dementia and psychiatric disorders. BMC Med. 20.","DOI":"10.1186\/s12916-022-02335-y"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0600","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12916-022-02335-y","article-title":"Shared genetic links between frontotemporal dementia and psychiatric disorders","volume":"20","author":"Li","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0605","article-title":"The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson\u2019s disease","volume":"15","author":"Li","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0610","doi-asserted-by":"crossref","unstructured":"Li JY, Cai ZY, Sun XH, Shen D chao, Yang XZ, Liu MS, et al. 2022. Blood\u2013brain barrier dysfunction and myelin basic protein in survival of amyotrophic lateral sclerosis with or without frontotemporal dementia. Neurol. Sci. 43:3201\u20133210.","DOI":"10.1007\/s10072-021-05731-z"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0615","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade1282","article-title":"Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines","volume":"9","author":"Licht-Murava","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0620","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/mp.2013.182","article-title":"Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats","volume":"19","author":"Lima","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0625","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.2174\/1381612819666140110115603","article-title":"NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer\u2019s disease","volume":"20","author":"Lin","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0630","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-023-02843-5","article-title":"Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer\u2019s disease-associated biomarkers alterations among de novo Parkinson\u2019s disease patients: a prospective cohort study","volume":"20","author":"Liu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0635","doi-asserted-by":"crossref","unstructured":"Liu Z, Fan Q, Wu S, Wan Y, Lei Y. 2021. Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson\u2019s disease. Lipids Health Dis 20.","DOI":"10.1186\/s12944-021-01462-4"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0640","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JGP.0b013e31823bc08c","article-title":"Age-associated differences in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults","volume":"20","author":"Loewenstein","year":"2012","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0645","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225674","article-title":"Excitatory amino acid transporters (Eaats): glutamate transport and beyond","volume":"20","author":"Magi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0650","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0006-3223(96)00546-X","article-title":"Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine","volume":"42","author":"Malhotra","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0655","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","article-title":"NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers","volume":"14","author":"Malhotra","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0660","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1093\/brain\/awad078","article-title":"Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia","volume":"146","author":"Malpetti","year":"2023","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.04.003_bib1166","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1038\/s41380-022-01683-8","article-title":"Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia","volume":"27","author":"Mastrogiacomo","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0665","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0670","doi-asserted-by":"crossref","unstructured":"Michalicova A, Majerova P, Kovac A. 2020. Tau protein and its role in blood\u2013brain barrier dysfunction. Front. Mol. Neurosci. 13.","DOI":"10.3389\/fnmol.2020.570045"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0675","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030571","article-title":"Dual roles of astrocyte-derived factors in regulation of blood-brain barrier function after brain damage","volume":"20","author":"Michinaga","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0680","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-444-64012-3.00003-4","article-title":"Frontotemporal dementia","volume":"165","author":"Miller","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0685","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0690","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/antiox11112275","article-title":"Systematic review of the therapeutic role of apoptotic inhibitors in neurodegeneration and their potential use in schizophrenia","volume":"11","author":"Mor\u00e9n","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0695","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuropsychologia.2015.10.030","article-title":"Detecting syntactic and semantic anomalies in schizophrenia","volume":"79","author":"Moro","year":"2015","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0700","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/319774a0","article-title":"Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5","volume":"319","author":"Morris","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0705","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14121281","article-title":"A new three-hit mouse model of neurodevelopmental disorder with cognitive impairments and persistent sociability deficits","volume":"14","author":"Mouffok","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0710","doi-asserted-by":"crossref","DOI":"10.1176\/appi.neuropsych.20240238","article-title":"Prevalence and features of misdiagnosis of primary psychiatric disorders among bvFTD patients","author":"Mukwikwi","year":"2025","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0715","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1093\/brain\/awaa305","article-title":"GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition","volume":"143","author":"Murley","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0720","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/brain\/awx327","article-title":"Neurotransmitter deficits from fronto temporal lobar degeneration","volume":"141","author":"Murley","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0725","doi-asserted-by":"crossref","unstructured":"Nakazawa K, Jeevakumar V, Nakao K. 2017. Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia. NPJ Schizophr 3.","DOI":"10.1038\/s41537-016-0003-3"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0730","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neuropharm.2011.01.022","article-title":"GABAergic interneuron origin of schizophrenia pathophysiology","volume":"62","author":"Nakazawa","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0735","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/glia.22930","article-title":"Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge","volume":"64","author":"Norden","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0740","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00406-021-01237-z","article-title":"Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions","volume":"271","author":"North","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0745","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031115","article-title":"Innate immunity: a common denominator between neurodegenerative and neuropsychiatric diseases","volume":"21","author":"Novellino","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0750","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214498","article-title":"Protein misfolding and aggregation in the brain: common pathogenetic pathways in neurodegenerative and mental disorders","volume":"23","author":"Ochneva","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0755","doi-asserted-by":"crossref","unstructured":"O\u2019Donovan SM, Sullivan CR, McCullumsmith RE. 2017. The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders. NPJ Schizophr. 3.","DOI":"10.1038\/s41537-017-0037-1"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0760","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/sj.npp.1300829","article-title":"Dopamine D1 and D4 receptor subtypes differentially modulate recurrent excitatory synapses in prefrontal cortical pyramidal neurons","volume":"31","author":"Onn","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0765","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cns.13768","article-title":"Kynurenic acid in neurodegenerative disorders\u2014unique neuroprotection or double-edged sword?","volume":"28","author":"Ostapiuk","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0770","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1038\/s41380-023-02293-8","article-title":"Genomic findings in schizophrenia and their implications","volume":"28","author":"Owen","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0775","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/schbul\/sbac159","article-title":"Language network dysfunction and formal thought disorder in schizophrenia","volume":"49","author":"Palaniyappan","year":"2023","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0780","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.1192\/j.eurpsy.2022.808","article-title":"Investigation of alpha-synuclein in patients with late-onset schizophrenia","volume":"65","author":"Palchikova","year":"2022","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0785","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/mp.2010.106","article-title":"Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine\/D2 pathways","volume":"17","author":"Papaleo","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0790","doi-asserted-by":"crossref","unstructured":"Pathak D, Sriram K. 2023. Neuron-astrocyte omnidirectional signaling in neurological health and disease. Front. Mol. Neurosci. 16.","DOI":"10.3389\/fnmol.2023.1169320"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110668","article-title":"The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: a systematic review and meta-analysis","volume":"121","author":"Patlola","year":"2023","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0800","article-title":"The role of dopamine receptors in lymphocytes and their changes in schizophrenia","volume":"12","author":"Penedo","year":"2021","journal-title":"Brain. Behav. Immun. Health"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0805","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s11064-006-9162-3","article-title":"Possible mechanisms of neurodegeneration in schizophrenia","volume":"31","author":"P\u00e9rez-Neri","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0810","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-022-02114-6","article-title":"The neurophysiological effect of NMDA-R antagonism of frontotemporal lobar degeneration is conditional on individual GABA concentration","volume":"12","author":"Perry","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0815","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awx254","article-title":"Clinicopathological correlations in behavioural variant frontotemporal dementia","volume":"140","author":"Perry","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0820","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuropharm.2014.10.017","article-title":"Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia","volume":"90","author":"Pershing","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.104987","article-title":"Neuroendocrine, neuroinflammatory and pathological outcomes of chronic stress: a story of microglial remodeling","volume":"145","author":"Picard","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0830","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/pharmrev.124.000239","article-title":"Neuroactive kynurenines as pharmacological targets: new experimental tools and exciting therapeutic opportunities","volume":"76","author":"Pocivavsek","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0835","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s00213-014-3452-2","article-title":"Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats","volume":"231","author":"Pocivavsek","year":"2014","journal-title":"Psychopharmacology"},{"issue":"Suppl","key":"10.1016\/j.neuroscience.2026.04.003_b0840","first-page":"1","article-title":"Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms","volume":"45","author":"Pogarell","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.018","article-title":"A role for tau at the synapse in Alzheimer\u2019s disease pathogenesis","volume":"76","author":"Pooler","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0850","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0855","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.schres.2014.09.043","article-title":"Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study","volume":"161","author":"Prasad","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0860","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015430","article-title":"The key role of astrocytes in amyotrophic lateral sclerosis and their commitment to glutamate excitotoxicity","volume":"24","author":"Provenzano","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0865","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neubiorev.2014.11.005","article-title":"Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications","volume":"48","author":"Rajasekaran","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0870","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2009.10.013","article-title":"Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients","volume":"116","author":"Rapp","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0875","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.160.5.867","article-title":"Amyloid \u03b2 pathology in Alzheimer\u2019s disease and schizophrenia","volume":"160","author":"Religa","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102123","article-title":"Factors affecting the GABAergic synapse function in Alzheimer\u2019s disease: focus on microRNAs","volume":"92","author":"Rivera","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0885","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/schbul\/sbu097","article-title":"Resting-state functional connectivity of the nucleus accumbens in auditory and visual hallucinations in schizophrenia","volume":"41","author":"Rolland","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0890","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7551\/mitpress\/15679.003.0019","article-title":"Translating prefrontal cortex insights to the clinic and society","author":"Rowe","year":"2024","journal-title":"The Frontal Cortex"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0895","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.freeradbiomed.2008.05.026","article-title":"Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: implications for neurodegenerative diseases","volume":"45","author":"Roy","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.04.003_b0900","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.pnpbp.2005.03.004","article-title":"(+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia","volume":"29","author":"Rung","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0905","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.728990","article-title":"Is Elevated neutrophil count and neutrophil-to-lymphocyte ratio a cause or consequence of schizophrenia? A scoping review","volume":"12","author":"Sandberg","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2013.06.019","article-title":"Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer\u2019s disease","volume":"48","author":"Santos","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0915","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/schbul\/sbad123","article-title":"Prefrontal and hippocampal parvalbumin interneurons in animal models for schizophrenia: a systematic review and meta-analysis","volume":"50","author":"Santos-Silva","year":"2024","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0920","doi-asserted-by":"crossref","unstructured":"Sapienza J, Agostoni G, Comai S, Nasini S, Dall\u2019Acqua S, Sut S, et al. 2024. Neuroinflammation and kynurenines in schizophrenia: impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise. Schizophr. Res. Cogn. 38:100328.","DOI":"10.1016\/j.scog.2024.100328"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0925","doi-asserted-by":"crossref","unstructured":"Sapienza J, Agostoni G, Dall\u2019Acqua S, Sut S, Nasini S, Martini F, et al. 2024. The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy. Schizophr. Res. 264:71\u201380.","DOI":"10.1016\/j.schres.2023.12.005"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0930","doi-asserted-by":"crossref","unstructured":"Sapienza J, Agostoni G, Repaci F, Spangaro M, Comai S, Bosia M. 2025. Metabolic syndrome and schizophrenia: adding a piece to the interplay between the kynurenine pathway and inflammation. Metabolites 15.","DOI":"10.3390\/metabo15030176"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0935","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.clinph.2024.03.013","article-title":"Dysconnection in schizophrenia: filling the dots from old to new evidence","volume":"162","author":"Sapienza","year":"2024","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0940","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00406-022-01519-0","article-title":"Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies","volume":"273","author":"Sapienza","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0945","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ana.25739","article-title":"Frontotemporal dementia: correlations between psychiatric symptoms and pathology","volume":"87","author":"Scarioni","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0950","doi-asserted-by":"crossref","DOI":"10.3390\/cells13020150","article-title":"Involvement of astrocytes in the formation, maintenance and function of the blood-brain barrier","volume":"13","author":"Schiera","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0955","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","article-title":"Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning","volume":"22","author":"Sellgren","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0960","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0031-9384(02)00931-9","article-title":"Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia","volume":"77","author":"Sesack","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0965","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13061691","article-title":"Insomnia in forensic detainees: is salience network the common pathway for sleep, neuropsychiatric, and neurodegenerative disorders?","volume":"13","author":"Sfera","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0970","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-140312","article-title":"Psychosis in frontotemporal dementia","volume":"42","author":"Shinagawa","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0975","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810145","article-title":"Non-canonical roles of tau and their contribution to synaptic dysfunction","volume":"22","author":"Siano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0980","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox9080743","article-title":"Ros generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease","volume":"9","author":"Simpson","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0985","doi-asserted-by":"crossref","unstructured":"Smeland OB, Frei O, Dale AM, Andreassen OA. 2020. The polygenic architecture of schizophrenia \u2014 rethinking pathogenesis and nosology. Nat. Rev. Neurol. 2020 16:7 16:366\u2013379.","DOI":"10.1038\/s41582-020-0364-0"},{"key":"10.1016\/j.neuroscience.2026.04.003_b0990","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuroscience.2026.04.003_b0995","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01739651","article-title":"Brain quinolinic acid in Alzheimer\u2019s dementia","volume":"239","author":"Sofic","year":"1989","journal-title":"Eur. Arch. Psychiatry Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1000","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1073858413504466","article-title":"Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators","volume":"20","author":"Sofroniew","year":"2014","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1005","first-page":"25","article-title":"The cellular dysfunction of the brain\u2013blood barrier from endothelial cells to astrocytes: the pathway towards neurotransmitter impairment in schizophrenia","author":"Stanca","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0306-4522(02)00298-1","article-title":"Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats","volume":"114","author":"Suzuki","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1015","doi-asserted-by":"crossref","unstructured":"Szumlinski KK;, Datko MC;, Lominac KD;, Jentsch J D, Abulseoud O, Szumlinski KK, et al. 2024. Dysbindin-1 mutation alters prefrontal cortex extracellular glutamate and dopamine in vivo. Int. J. Mol. Sci. 2024, Vol. 25, Page 12732 25:12732.","DOI":"10.3390\/ijms252312732"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1020","doi-asserted-by":"crossref","unstructured":"Taipa R, das Neves SP, Sousa AL, Fernandes J, Pinto C, Correia AP, et al. 2019. Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer\u2019s disease and their correlation with cognitive decline. Neurobiol Aging 76:125\u2013132.","DOI":"10.1016\/j.neurobiolaging.2018.12.019"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1025","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1093\/hmg\/ddl246","article-title":"Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin","volume":"15","author":"Talbot","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030564","article-title":"Are kynurenines accomplices or principal villains in dementia? Maintenance of kynurenine metabolism","volume":"25","author":"Tanaka","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, \u201cjust the facts\u201d 4. Clinical features and conceptualization","volume":"110","author":"Tandon","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1040","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1038\/s41380-020-01008-7","article-title":"Natural killer cells in first-episode psychosis: an innate immune signature?","volume":"26","author":"Tarantino","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01612","article-title":"Alterations of astrocytes in the context of schizophrenic dementia","volume":"10","author":"Tarasov","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1050","first-page":"118","article-title":"Whole-blood metabolomics of dementia patients reveal classes of disease-linked metabolites","author":"Teruya","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1055","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1073\/pnas.1719897115","article-title":"Deletion of dopamine D2 receptors from parvalbumin interneurons in mouse causes schizophrenialike phenotypes","volume":"115","author":"Tomasella","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1060","first-page":"11","article-title":"Dystrophy of oligodendrocytes and adjacent microglia in prefrontal gray matter in schizophrenia","author":"Uranova","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biopsych.2016.10.011","article-title":"New concepts in dopamine D2 receptor biased signaling and implications for schizophrenia therapy","volume":"81","author":"Urs","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/metabo14010030","article-title":"Altered sphingolipid hydrolase activities and alpha-synuclein level in late-onset schizophrenia","volume":"14","author":"Usenko","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1075","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.3390\/ijms23052810","article-title":"Neuroinflammation in schizophrenia: the key role of the WNT\/\u03b2-catenin pathway","volume":"23","author":"Vall\u00e9e","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1080","doi-asserted-by":"crossref","DOI":"10.3390\/cells12111450","article-title":"Astrocytes: dissecting their diverse roles in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"12","author":"Valori","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1085","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/00048670903001984","article-title":"Abnormal hippocampal distribution of TDP-43 in patients with-late onset psychosis","volume":"43","author":"Velakoulis","year":"2009","journal-title":"Austr. New Zealand J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1090","first-page":"11","article-title":"Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration","author":"Verma","year":"2022","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1095","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.116","article-title":"Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies","volume":"2","author":"Vita","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01638","article-title":"Developmental genes and regulatory proteins, domains of cognitive impairment in schizophrenia spectrum psychosis and implications for antipsychotic drug discovery: the example of dysbindin-1 isoforms and beyond","volume":"10","author":"Waddington","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/S1740925X12000063","article-title":"Functions of microglia in the central nervous system-beyond the immune response","volume":"7","author":"Wake","year":"2012","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1110","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2174\/13894501113149990208","article-title":"Acute and chronic stress-induced disturbances of microglial plasticity, phenotype and function","volume":"14","author":"Walker","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1115","doi-asserted-by":"crossref","first-page":"E1256","DOI":"10.1212\/WNL.0000000000007094","article-title":"Systemic inflammation during midlife and cognitive change over 20 years: the ARIC Study","volume":"92","author":"Walker","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102044","article-title":"Dysbindin-1 involvement in the etiology of schizophrenia","volume":"18","author":"Wang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1125","doi-asserted-by":"crossref","first-page":"16482","DOI":"10.1523\/JNEUROSCI.3418-14.2014","article-title":"Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia","volume":"34","author":"Warmus","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archpsyc.61.6.544","article-title":"Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain","volume":"61","author":"Weickert","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1135","first-page":"81","article-title":"Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics","volume":"43","author":"Wierzba-Bobrowicz","year":"2005","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1140","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","article-title":"Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: a Mendelian randomization study","volume":"79","author":"Williams","year":"2022","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1145","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1150","doi-asserted-by":"crossref","first-page":"12296","DOI":"10.1523\/JNEUROSCI.2962-16.2016","article-title":"Glutamate induces blood\u2013brain barrier permeability through activation of N-methyl-D-aspartate receptors","volume":"36","author":"Xhima","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuroscience.2016.07.008","article-title":"The pathogenic mechanism of dysbindin-1B toxic aggregation: BLOC-1 and intercellular vesicle trafficking","volume":"333","author":"Yang","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2026.04.003_b1160","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/jamapsychiatry.2022.0799","article-title":"Cortical thickness abnormalities at different stages of the illness course in schizophrenia: a systematic review and meta-analysis","volume":"79","author":"Zhao","year":"2022","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.neuroscience.2026.04.003_b1165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-023-00370-z","article-title":"Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions","volume":"9","author":"Zhuo","year":"2023","journal-title":"Schizophrenia"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226002551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226002551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:47:07Z","timestamp":1793598427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226002551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":234,"alternative-id":["S0306452226002551"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.04.003","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Schizophrenia and frontotemporal dementia: distinct diseases with converging circuit dysfunctions","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}